Experience

ProfoundBio Announces $112 Million Oversubscribed Series B

February 14, 2024

Cooley advised ProfoundBio, a clinical-stage biotechnology company developing novel antibody-drug conjugate therapeutics for patients with cancer, on its $112 million oversubscribed Series B financing.

Read more

Related contacts

Patrick Loofbourrow
Partner, Singapore
Monica Xu
Counsel, Shanghai
Ivy Wang
Associate, Shanghai
Zixiang Liu
Associate, Shanghai
Sherlyn Qu
Legal Consultant, Shanghai
Xander Lee
Partner, Los Angeles Santa Monica
Charlie Kim
Partner, San Diego
Christopher Kimball
Partner, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Sarah Oliai
Associate, Washington, DC
Letian Wei
Legal Consultant, Shanghai
Teresa Yang
Legal Consultant, Shanghai

Related Practices & Industries

2023 05 11 NeuExcell Therapeutics Announces 15 Million Series Pre-A

NeuExcell Therapeutics Announces $15 Million Series Pre-A+

May 15, 2023

Cooley advised NeuExcell Therapeutics, a neurodegenerative disease gene therapy company, on its $15 million+ Series Pre-A+ financing round.

Read more

Related contacts

Christina Zhang
Partner, Shanghai
Lunga Su
Associate, Shanghai
Teresa Yang
Legal Consultant, Shanghai

Related Practices & Industries

SJ Semiconductor Signs $340 Million Series C+ Financing

April 12, 2023

Cooley advised SJ Semiconductor Corporation (SJSemi), a semiconductor foundry, on its $340 million Series C+ financing, with a post-money valuation of close to US$2 billion.

Related contacts

Ruomu Li
Partner, Shanghai
Wenlan Geng
Associate, Shanghai
Teresa Yang
Legal Consultant, Shanghai
Zixiang Liu
Associate, Shanghai
Sherlyn Qu
Legal Consultant, Shanghai

Related Practices & Industries